Delivery Order SPE2DB22D3016-SPE2DB25FAPX8
Award Date
3/3/25
Potential Completion Date
3/4/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.62, is for the delivery of Moxifloxacin HCL 400 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,584.38, is for the delivery of 4567410604 MOXIFLOXACIN HCL 400 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,423.55 and an ultimate completion date of August 19, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.55 firm fixed-price delivery order is for 50 units of the medication Moxifloxacin HCl 400 mg Tablet. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,013.60 firm fixed-price contract is for the delivery of 4,564,603,860 tablets of the antibiotic moxifloxacin hydrochloride 400 milligrams. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 4,567,089,253 units of Moxifloxacin HCL 400 mg tablets. The award has a ceiling value of $20,097.88 and an ultimate completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of 4,567,320,273 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 20, 2025. The contract is a Delivery Order with a Firm Fixed Price of $2,691.00 and a completion date of February 21, 2025. The contract does not have a set-aside designation. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4,567,049,952 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,342.70 and is a firm fixed price delivery order without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,094.28, is a firm fixed-price delivery order to provide 4,565,047,008 units of the medication Moxifloxacin HCL 400 mg Tablet. The ultimate completion date for this contract is July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,307.14, is for the delivery of moxifloxacin HCL 400 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...